Cargando…
Low c-Met expression levels are prognostic for and predict the benefits of temozolomide chemotherapy in malignant gliomas
Aberrant c-Met has been implicated in the development of many cancers. The objective of this study was to identify an unfavorable prognostic marker that might guide decisions regarding clinical treatment strategies for high-grade gliomas. C-Met expression was measured using immunohistochemistry in 7...
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4754763/ https://www.ncbi.nlm.nih.gov/pubmed/26879272 http://dx.doi.org/10.1038/srep21141 |